- Received “Pass” from two tech evaluation agencies… Target to file preliminary review application to KOSDAQ
- Expanding global new drug development platform through IPO. Accelerating innovation for new drug development and business development
(For more information, please refer to the link below)
https://www.hankyung.com/it/article/201912276015i